Catabasis Pharma (CATB) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. VRTX
5. CHKP
6. ON
7. HNGE
8. INSP
9. AXSM
10. RXRX

Go back to Catabasis Pharma (CATB) Tops Q2 EPS by 3c

Catabasis Pharmaceuticals Reports Second Quarter 2018 Financial Results and Reviews Business Progress

August 9, 2018 8:06 AM EDT

-- Edasalonexent Phase 3 PolarisDMD Trial in Duchenne Muscular Dystrophy Expected to Initiate in the Second Half of 2018 --

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB), a clinical-stage biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2018, and reviewed recent business progress.

We are thrilled to have... More